1.Comparative outcomes of separate versus pantaloon anastomosis in two renal artery living donor kidney transplantation:a retrospective cohort study
Asad BASHIR ; Zia Ul Haq AKRAM ; Nasrum MINALLAH ; Fiaz Ahmad TOUQEER ; Ali ASAD ; Mariam ASAD ; Zaghum SHAZAD ; Muhammad Faheem ASLAM ; Sehrish TEHREEM ; Ammar YOUSAF
Clinical Transplantation and Research 2025;39(4):326-334
Background:
The optimal surgical approach for managing multiple renal arteries in living donor kidney transplantation remains unclear. This study compared outcomes between separate anastomoses (SA) and pantaloon anastomosis (PA).
Methods:
A retrospective cohort study was conducted from November 2018 to August 2024. In total, 117 patients were included (SA, 67; PA, 50). The primary outcome was arterial complications. Secondary outcomes included renal function, graft and patient survival at 1 year, and intraoperative variables. Statistical analyses utilized the t-test, the Mann-Whitney U-test, and Kaplan-Meier survival curves.
Results:
The mean warm ischemia time was similar between groups (105.48±35.64 vs.103.92±33.51 min; P=0.811). Cold ischemia time was also comparable (75.90±14.36 vs.80.68±17.85 min; P=0.111). However, anastomosis time was significantly longer in the SA group (39.00 [35.00–43.00] min) compared with the PA group (34.00 [28.50–39.50] min; P<0.001). The immediate postoperative creatinine reduction was slightly greater in the SA group (46.83%±20.68% vs. 39.78%±19.04%; P=0.090). Vascular complications requiring re-exploration were infrequent in both groups (1.5% vs. 2.0%). At 1 year posttransplant, creatinine levels were comparable between the SA (1.20 [0.95–1.45] mg/dL) and PA (1.20 [1.05–1.35] mg/dL) groups (P=0.337). Regression analysis confirmed that postoperative creatinine levels were independently associated with SA (P=0.006). Graft survival was similarly high (97% vs. 98%), as was patient survival (100% vs. 96%).
Conclusions
Both anastomosis techniques are safe and effective for transplanting kidneys with anatomical anomalies. SA offers surgical efficiency and provides superior early renal recovery.
2. Pharmacological basis for the medicinal use of Michelia champaca in gut, airways and cardiovascular disorders
Fatima SAQIB ; Zubia MUSHTAQ ; Khalid JANBAZ ; Imran IMRAN ; Saikat DEAWNJEE ; Muhammad ZIA-UL-HAQ ; Lorena DIMA
Asian Pacific Journal of Tropical Medicine 2018;11(4):292-296
Objective: To discover the mechanism behind ameliorative effects of Michelia champaca (M. champaca) in gastrointestinal, respiratory and cardiovascular disorders. Methods: Anti- spasmodic potential was evaluated by trying the M. champaca extract (aqueous:ethanolic) on rabbit aorta, trachea and jejunum in vitro. Isotonic and isometric transducers coupled with Power Lab data acquisition system was used to record the responses of isolated tissues. Results: M. champaca extract relaxed the spontaneous and high K

Result Analysis
Print
Save
E-mail